NCT00449956View on ClinicalTrials.gov

MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

474

Participants

Timeline

Start Date

March 12, 2007

Primary Completion Date

February 16, 2008

Study Completion Date

February 16, 2008

Conditions
Glaucoma
Interventions
DRUG

dorzolamide hydrochloride (+) timolol maleate

Dorzolamide hydrochloride 1% + timolol 0.5%, 8-week

DRUG

Comparator: timolol maleate

timolol maleate 0.5%, 8-week

DRUG

Comparator: dorzolamide hydrochloride

dorzolamide hydrochloride 1%, 8-week

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00449956 - MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED) | Biotech Hunter | Biotech Hunter